{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:29:10Z","timestamp":1791937750726,"version":"4.3.4"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,4,2]],"date-time":"2018-04-02T00:00:00Z","timestamp":1522627200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1007\/s11926-018-0735-3","type":"journal-article","created":{"date-parts":[[2018,4,2]],"date-time":"2018-04-02T05:03:22Z","timestamp":1522645402000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["IgA Vasculitis: Genetics and Clinical and Therapeutic Management"],"prefix":"10.1007","volume":"20","author":[{"given":"Miguel A.","family":"Gonz\u00e1lez-Gay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"L\u00f3pez-Mej\u00edas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trinitario","family":"Pina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santos","family":"Casta\u00f1eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,2]]},"reference":[{"key":"735_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.37715","volume":"65","author":"JC Jennette","year":"2013","unstructured":"Jennette JC, Falk RJ, Bacon PA, et al. 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 2013;65:1\u201311.","journal-title":"Arthritis Rheum"},{"key":"735_CR2","first-page":"56","volume":"17","author":"MA Gonzalez-Gay","year":"2005","unstructured":"Gonzalez-Gay MA, Garcia-Porrua C, Pujol RM. Clinical approach to cutaneous vasculitis. Curr Opin Rheumatol. 2005;17:56\u201361.","journal-title":"Curr Opin Rheumatol"},{"key":"735_CR3","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/S0889-857X(05)70232-5","volume":"27","author":"MA Gonz\u00e1lez-Gay","year":"2001","unstructured":"Gonz\u00e1lez-Gay MA, Garc\u00eda-Porr\u00faa C. Epidemiology of the vasculitides. Rheum Dis Clin N Am. 2001;27:729\u201349.","journal-title":"Rheum Dis Clin N Am"},{"key":"735_CR4","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1097\/00005792-200109000-00001","volume":"80","author":"MC Calvi\u00f1o","year":"2001","unstructured":"Calvi\u00f1o MC, Llorca J, Garc\u00eda-Porr\u00faa C, Fern\u00e1ndez-Iglesias JL, Rodr\u00edguez-Ledo P, Gonzalez-Gay MA. Henoch-Sch\u00f6nlein purpura in children from northwestern Spain: a 20-year epidemiologic and clinical study. Medicine (Baltimore). 2001;80:279\u201390.","journal-title":"Medicine (Baltimore)"},{"key":"735_CR5","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1053\/sarh.2002.33980","volume":"32","author":"C Garc\u00eda-Porr\u00faa","year":"2002","unstructured":"Garc\u00eda-Porr\u00faa C, Calvi\u00f1o MC, Llorca J, Couselo JM, Gonz\u00e1lez-Gay MA. Henoch-Sch\u00f6nlein purpura in children and adults: clinical differences in a defined population. Semin Arthritis Rheum. 2002;32:149\u201356.","journal-title":"Semin Arthritis Rheum"},{"key":"735_CR6","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1093\/rheumatology\/kex158","volume":"56","author":"M Piram","year":"2017","unstructured":"\u2022 Piram M, Maldini C, Biscardi S, et al. Incidence of IgA vasculitis in children estimated by four-source capture-recapture analysis: a population-based study. Rheumatology (Oxford). 2017;56:1358\u201366. According to these investigators, an important number of children with of IgAV remains unrecognized in epidemiological surveys.","journal-title":"Rheumatology (Oxford)"},{"issue":"18","key":"735_CR7","doi-asserted-by":"publisher","first-page":"30012","DOI":"10.1016\/j.autrev.2017.11.024","volume":"S1568\u20139972","author":"R L\u00f3pez-Mej\u00edas","year":"2018","unstructured":"\u2022\u2022 L\u00f3pez-Mej\u00edas R, Casta\u00f1eda S, Genre F, et al. Genetics of immunoglobulin-A vasculitis (Henoch-Sch\u00f6nlein purpura): an updated review. Autoimmun Rev. 2018;S1568\u20139972(18):30012\u20130. https:\/\/doi.org\/10.1016\/j.autrev.2017.11.024 . Comprehensive review of genetics in patients with IgA vasculitis. Besides an association with HLA-region, in particular with HLA-DRB1 alleles, other gene polymorphisms appear to be implicated in the susceptibility to IgAV as well as the risk of nephritis.","journal-title":"Autoimmun Rev"},{"key":"735_CR8","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1002\/art.38979","volume":"67","author":"R L\u00f3pez-Mej\u00edas","year":"2015","unstructured":"\u2022\u2022 L\u00f3pez-Mej\u00edas R, Genre F, P\u00e9rez BS, et al. HLA-DRB1 association with Henoch-Schonlein purpura. Arthritis Rheumatol. 2015;67:823\u20137. This study confirms the association of IgA with HLA-DRB1*01 in Caucasians. Data from this study indicate the presence of protective alleles against the development of IgA vasculitis, such as the HLA-DRB1*03, in Caucasians","journal-title":"Arthritis Rheumatol"},{"key":"735_CR9","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s13075-015-0622-5","volume":"17","author":"R L\u00f3pez-Mej\u00edas","year":"2015","unstructured":"\u2022 L\u00f3pez-Mej\u00edas R, Genre F, P\u00e9rez BS, et al. Association of HLA-B*41:02 with Henoch-Sch\u00f6nlein Purpura (IgA Vasculitis) in Spanish individuals irrespective of the HLA-DRB1 status. Arthritis Res Ther. 2015;17:102. Association of IgA vasculitis in Spanish individuals with HLA-class I, in particular with HLA-B*41:02 independently of the previously reported associated with HLA-DRB1*01:03.","journal-title":"Arthritis Res Ther"},{"key":"735_CR10","doi-asserted-by":"publisher","first-page":"5088","DOI":"10.1038\/s41598-017-03915-2","volume":"7","author":"R L\u00f3pez-Mej\u00edas","year":"2017","unstructured":"\u2022\u2022 L\u00f3pez-Mej\u00edas R, Carmona FD, Casta\u00f1eda S, et al. A genome-wide association study suggests the HLA Class II region as the major susceptibility locus for IgA vasculitis. Sci Rep. 2017;7:5088. This is the first genome wide association study n IgA vasculitis. This study shows that IgA vasculitis is an archetypal HLA class II disease. Other gene polymorphisms located outside this region may also account for the susceptibility to IgA vasculitis.","journal-title":"Sci Rep"},{"key":"735_CR11","first-page":"1404","volume":"29","author":"MM Amoli","year":"2002","unstructured":"Amoli MM, Thomson W, Hajeer AH, et al. Interleukin 1 receptor antagonist gene polymorphism is associated with severe renal involvement and renal sequelae in Henoch-Sch\u00f6nlein purpura. J Rheumatol. 2002;29:1404\u20137.","journal-title":"J Rheumatol"},{"key":"735_CR12","first-page":"2367","volume":"29","author":"MM Amoli","year":"2002","unstructured":"Amoli MM, Thomson W, Hajeer AH, et al. Interleukin 8 gene polymorphism is associated with increased risk of nephritis in cutaneous vasculitis. J Rheumatol. 2002;29:2367\u201370.","journal-title":"J Rheumatol"},{"key":"735_CR13","first-page":"69","volume":"33","author":"B Rueda","year":"2006","unstructured":"Rueda B, Perez-Armengol C, Lopez-Lopez S, Garcia-Porrua C, Mart\u00edn J, Gonzalez-Gay MA. Association between functional haplotypes of vascular endothelial growth factor and renal complications in Henoch-Sch\u00f6nlein purpura. J Rheumatol. 2006;33:69\u201373.","journal-title":"J Rheumatol"},{"key":"735_CR14","first-page":"1081","volume":"32","author":"J Martin","year":"2005","unstructured":"Martin J, Paco L, Ruiz MP, et al. Inducible nitric oxide synthase polymorphism is associated with susceptibility to Henoch-Sch\u00f6nlein purpura in northwestern Spain. J Rheumatol. 2005;32:1081\u20135.","journal-title":"J Rheumatol"},{"issue":"3 Suppl 82","key":"735_CR15","first-page":"S141","volume":"32","author":"R L\u00f3pez-Mej\u00edas","year":"2014","unstructured":"L\u00f3pez-Mej\u00edas R, Sevilla P\u00e9rez B, Genre F, et al. Lack of association between IL6 gene and Henoch-Sch\u00f6nlein purpura. Clin Exp Rheumatol. 2014;32(3 Suppl 82):S141\u20132.","journal-title":"Clin Exp Rheumatol"},{"key":"735_CR16","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1186\/s13075-015-0796-x","volume":"17","author":"R L\u00f3pez-Mej\u00edas","year":"2015","unstructured":"L\u00f3pez-Mej\u00edas R, Genre F, Remuzgo-Mart\u00ednez S, et al. Role of PTPN22 and CSK gene polymorphisms as predictors of susceptibility and clinical heterogeneity in patients with Henoch-Sch\u00f6nlein purpura (IgA vasculitis). Arthritis Res Ther. 2015;17:286.","journal-title":"Arthritis Res Ther"},{"key":"735_CR17","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1097\/MD.0000000000000019","volume":"93","author":"V Calvo-R\u00edo","year":"2014","unstructured":"\u2022 Calvo-R\u00edo V, Loricera J, Mata C, et al. Henoch-Sch\u00f6nlein purpura in northern Spain: clinical spectrum of the disease in 417 patients from a single center. Medicine (Baltimore). 2014;93:106\u201313. Study supporting the claim that IgA vasculitis is mainly a childhood disease. Data from this series of unselected patients showed that the outcome is good in most cases, depending largely on renal involvement.","journal-title":"Medicine (Baltimore)"},{"key":"735_CR18","doi-asserted-by":"publisher","first-page":"198","DOI":"10.3346\/jkms.2014.29.2.198","volume":"29","author":"Y Kang","year":"2014","unstructured":"\u2022 Kang Y, Park JS, Ha YJ, et al. Differences in clinical manifestations and outcomes between adult and child patients with Henoch-Sch\u00f6nlein purpura. J Korean Med Sci. 2014;29:198\u2013203. Study in Korean patients that further supports the worse outcome and the higher frequency of chronic renal failure in adults when compared with children with IgA vasculitis","journal-title":"J Korean Med Sci"},{"key":"735_CR19","doi-asserted-by":"publisher","unstructured":"\u2022 Gupta V, Aggarwal A, Gupta R, et al. Differences between adult and pediatric onset Henoch-Schonlein purpura from North India. Int J Rheum Dis 2017. https:\/\/doi.org\/10.1111\/1756-185X.13221 . Unlike most studies, in this study from Northern India no clear differences in the risk of nephritis and outcome were seen between children and adults with IgA vasculitis.","DOI":"10.1111\/1756-185X.13221"},{"issue":"Suppl 103","key":"735_CR20","first-page":"3","volume":"35","author":"MA Gonz\u00e1lez-Gay","year":"2017","unstructured":"\u2022 Gonz\u00e1lez-Gay MA, Blanco R, Casta\u00f1eda S. Henoch-Sch\u00f6nlein purpura (IgA vasculitis): the paradox of the different incidence and clinical spectrum in children and adults. Clin Exp Rheumatol. 2017;35(Suppl 103):3\u20134. Article addressing the paradox of the lower frequency and worse prognosis of IgA vasculitis in adulthood when compared with that of childhood","journal-title":"Clin Exp Rheumatol"},{"key":"735_CR21","doi-asserted-by":"publisher","first-page":"e0167346","DOI":"10.1371\/journal.pone.0167346","volume":"11","author":"H Chan","year":"2016","unstructured":"\u2022\u2022 Chan H, Tang YL, Lv XH, et al. Risk factors associated with renal involvement in childhood Henoch-Sch\u00f6nlein Purpura: a meta-analysis. PLoS One. 2016;11:e0167346. A meta-analysis that assessed the predictors of nephritis in 2398 children with IgA vasculitis. Male gender, an age older than 10 years old, presence of severe manifestations or persistent purpura were associated with higher risk of nephritis. It was also the case for those who had relapses, leukocytosis, thrombocytosis; elevated antistreptolysin O titer and low C3.","journal-title":"PLoS One"},{"issue":"3 Suppl 97","key":"735_CR22","first-page":"S77","volume":"34","author":"S Hong","year":"2016","unstructured":"\u2022\u2022 Hong S, Ahn SM, Lim DH, et al. Late-onset IgA vasculitis in adult patients exhibits distinct clinical characteristics and outcomes. Clin Exp Rheumatol. 2016;34(3 Suppl 97):S77\u201383. The clinical spectrum and outcome of adults with IgA vasculitis depends on the age of onset. Individuals aged 60 years and older age have more commonly nephritis, diabetes and hypertension at the onset of the vasculitis and are more commonly associated with malignancy. Late-onset adults with IgA vasculitis have an increased risk of chronic kidney disease, end-stage renal failure and death than the patients with IgA vasculitis older than 20 and younger than 60 years.","journal-title":"Clin Exp Rheumatol"},{"key":"735_CR23","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1097\/DAD.0b013e3182157f90","volume":"34","author":"JW Byun","year":"2012","unstructured":"Byun JW, Song HJ, Kim L, Shin JH, Choi GS. Predictive factors of relapse in adults with Henoch-Sch\u00f6nlein purpura. Am J Dermatopathol. 2012;34:139\u201344.","journal-title":"Am J Dermatopathol"},{"key":"735_CR24","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1097\/01.rhu.0000255692.46165.19","volume":"13","author":"D Prais","year":"2007","unstructured":"Prais D, Amir J, Nussinovitch M. Recurrent Henoch-Sch\u00f6nlein purpura in children. J Clin Rheumatol. 2007;13:25\u20138.","journal-title":"J Clin Rheumatol"},{"key":"735_CR25","doi-asserted-by":"publisher","first-page":"e4217","DOI":"10.1097\/MD.0000000000004217","volume":"95","author":"V Calvo-R\u00edo","year":"2016","unstructured":"\u2022 Calvo-R\u00edo V, Hern\u00e1ndez JL, Ortiz-Sanju\u00e1n F, et al. Relapses in patients with Henoch-Sch\u00f6nlein purpura: analysis of 417 patients from a single center. Medicine (Baltimore). 2016;95:e4217. Relapses occurred in almost one-third of 417 unselected patients with IgA vascultis. The clinical features at the time of the relapses were similar to those found at the time of disease diagnosis. Patients presenting with joint or gastrointestinal manifestations at the time of diagnosis of IgA vasculitis had more commonly relapses.","journal-title":"Medicine (Baltimore)"},{"key":"735_CR26","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.jaad.2017.04.1122","volume":"78","author":"J St John","year":"2018","unstructured":"\u2022 St John J, Vedak P, Garza-Mayers AC, Hoang MP, Nigwekar SU, Kroshinsky D. Location of skin lesions in Henoch-Sch\u00f6nlein purpura and its association with significant renal involvement. J Am Acad Dermatol. 2018;78:115\u201320. A retrospective study suggesting that the skin lesion distribution on the extremities may be a predictor of long-term renal involvement in adults with IgA vasculitis.","journal-title":"J Am Acad Dermatol"},{"key":"735_CR27","first-page":"1019","volume":"28","author":"C Garc\u00eda-Porr\u00faa","year":"2001","unstructured":"Garc\u00eda-Porr\u00faa C, Gonz\u00e1lez-Louzao C, Llorca J, Gonz\u00e1lez-Gay MA. Predictive factors for renal sequelae in adults with Henoch-Sch\u00f6nlein purpura. J Rheumatol. 2001;28:1019\u201324.","journal-title":"J Rheumatol"},{"key":"735_CR28","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.autrev.2015.02.003","volume":"14","author":"A Audemard-Verger","year":"2015","unstructured":"\u2022\u2022 Audemard-Verger A, Pillebout E, Guillevin L, Thervet E, Terrier B. IgA vasculitis (Henoch-Sh\u00f6nlein purpura) in adults: diagnostic and therapeutic aspects. Autoimmun Rev. 2015;14:579\u201385. The presence of renal impairment or proteinuria excretion exceeding 1 g\/24 hours at the time of disease diagnosis and the degree of renal damage on the kidney biopsy are the best predictors of end-stage renal failure in adults with IgA vasculitis.","journal-title":"Autoimmun Rev"},{"key":"735_CR29","doi-asserted-by":"publisher","first-page":"e0130536","DOI":"10.1371\/journal.pone.0130536","volume":"10","author":"X He","year":"2015","unstructured":"\u2022 He X, Yin W, Ding Y, et al. Higher serum angiotensinogen is an indicator of IgA vasculitis with nephritis revealed by comparative proteomes analysis. PLoS One. 2015;10:e0130536. The authors performed a comparative analysis of serum proteomes and they found that angiotensinogen concentration correlates with nephritis in patients with IgA vasculitis and that it may be used as a potential marker for the progression of IgA vasculitis.","journal-title":"PLoS One"},{"key":"735_CR30","doi-asserted-by":"publisher","first-page":"e0188718","DOI":"10.1371\/journal.pone.0188718","volume":"12","author":"E Pillebout","year":"2017","unstructured":"\u2022\u2022 Pillebout E, Jamin A, Ayari H, et al. Biomarkers of IgA vasculitis nephritis in children. PLoS One. 2017;12:e0188718. Study aimed to identify serum and urinary biomarkers of nephritis in children with IgA vasculitis.","journal-title":"PLoS One"},{"key":"735_CR31","doi-asserted-by":"publisher","unstructured":"\u2022\u2022 Berthelot L, Jamin A, Viglietti D, et al. Value of biomarkers for predicting immunoglobulin A vasculitis nephritis outcome in an adult prospective cohort. Nephrol Dial Transplant 2017. https:\/\/doi.org\/10.1093\/ndt\/gfx300 . Interesting study focused on the search of biomarkers of nephritis in adults with IgA vasculitis. The levels of urinary IgA at the onset of the disease predicted a poor renal outcome after 1 year of follow-up.","DOI":"10.1093\/ndt\/gfx300"},{"key":"735_CR32","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1111\/jdv.14176","volume":"31","author":"GR Nagy","year":"2017","unstructured":"\u2022 Nagy GR, Kem\u00e9ny L. Bata-Cs\u00f6rg\u0151 Z. Neutrophil-to-lymphocyte ratio: a biomarker for predicting systemic involvement in adult IgA vasculitis patients. J Eur Acad Dermatol Venereol. 2017;31:1033\u20137. The neutrophil-to-lymphocyte ratio may be a potential prognostic factor of systemic involvement in adults with IgA vasculitis.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"735_CR33","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.jpeds.2006.03.024","volume":"149","author":"J Ronkainen","year":"2006","unstructured":"Ronkainen J, Koskimies O, Ala-Houhala M, et al. Early prednisone therapy in Henoch-Sch\u00f6nlein purpura: a randomized, double-blind, placebo-controlled trial. J Pediatr. 2006;149:241\u20137.","journal-title":"J Pediatr"},{"key":"735_CR34","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1542\/peds.2009-3348","volume":"126","author":"PF Weiss","year":"2010","unstructured":"Weiss PF, Klink AJ, Localio R, et al. Corticosteroids may improve clinical outcomes during hospitalization for Henoch-Sch\u00f6nlein purpura. Pediatrics. 2010;126:674\u201381.","journal-title":"Pediatrics"},{"key":"735_CR35","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Hahn D, Hodson EM, Willis NS, Craig JC. Interventions for preventing and treating kidney disease in Henoch-Sch\u00f6nlein Purpura (HSP). Cochrane Database Syst Rev 2015; (8):CD005128. A review article showing that the use of prednisone and antiplatelet agents does not seem to prevent persistent kidney disease in children with IgA vasculitis. No evidence of benefit for cyclophosphamide therapy in children or adults with IgA vasculitis and severe kidney disease was found. The authors of this review concluded that data on mycophenolate mofetil or cyclosporine potential efficacy in IgA vasculitis nephritis are still scarce to draw strong conclusions.","DOI":"10.1002\/14651858.CD005128.pub3"},{"key":"735_CR36","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s00467-011-2057-9","volume":"27","author":"Y Du","year":"2012","unstructured":"Du Y, Hou L, Zhao C, Han M, Wu Y. Treatment of children with Henoch-Sch\u00f6nlein purpura nephritis with mycophenolate mofetil. Pediatr Nephrol. 2012;27:765\u201371.","journal-title":"Pediatr Nephrol"},{"key":"735_CR37","doi-asserted-by":"publisher","unstructured":"\u2022 Hackl A, Becker JU, K\u00f6rner LM, et al. Mycophenolate mofetil following glucocorticoid treatment in Henoch-Sch\u00f6nlein purpura nephritis: the role of early initiation and therapeutic drug monitoring. Pediatr Nephrol 2017. https:\/\/doi.org\/10.1007\/s00467-017-3846-6 . According to this study based on 18 patients seen at a single center, mycophenolate mofetil may be safe and potentially effective as a secondary therapeutic option for children with nephritis in the setting of IgA vasculitis.","DOI":"10.1007\/s00467-017-3846-6"},{"key":"735_CR38","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.autrev.2015.02.003","volume":"14","author":"A Audemard-Verger","year":"2015","unstructured":"\u2022\u2022 Audemard-Verger A, Pillebout E, Guillevin L, Thervet E, Terrier B. IgA vasculitis (Henoch-Sch\u00f6nlein purpura) in adults: diagnostic and therapeutic aspects. Autoimmun Rev. 2015;14:579\u201385. Interesting review focused on diagnostic and therapeutic aspects of IgA vasculitis in adults. The outcome of adults with IgA vasculitis is sometimes unexpected. There is an absence of correlation between the initial presentation and the long-term renal outcome. Treatment of severe involvement, including severe gastrointestinal complications or proliferative glomerulonephritis, remains controversial.","journal-title":"Autoimmun Rev"},{"key":"735_CR39","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1002\/art.40178","volume":"69","author":"A Audemard-Verger","year":"2017","unstructured":"\u2022\u2022 Audemard-Verger A, Terrier B, Dechartres A, et al. Characteristics and management of IgA vasculitis (Henoch-Sch\u00f6nlein) in adults: data From 260 patients included in a French multicenter retrospective survey. Arthritis Rheumatol. 2017;69:1862\u201370. Retrospective survey on 260 adults with IgA vasculitis included in a French multicenter study. Glucocorticoids alone constitute the first-line therapy in patients with IgA vasculitis. The benefit of adding cyclophosphamide to glucocorticoids in adults with IgA vasculitis remains unclear.","journal-title":"Arthritis Rheumatol"},{"key":"735_CR40","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/art.40339","volume":"70","author":"F Maritati","year":"2018","unstructured":"\u2022\u2022 Maritati F, Fenoglio R, Pillebout E, et al. Rituximab for the treatment of adult-onset IgA vasculitis (Henoch-Sch\u00f6nlein). Arthritis Rheumatol. 2018;70:109\u201314. In a series of 22 adults with IgA vasculitis, the remission rate following rituximab therapy was 91%. Most patients had remission within six months of this therapy.","journal-title":"Arthritis Rheumatol"},{"key":"735_CR41","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1159\/000188480","volume":"69","author":"G Rostoker","year":"1995","unstructured":"Rostoker G, Desvaux-Belghiti D, Pilatte Y, et al. Immunomodulation with low-dose immunoglobulins for moderate IgA nephropathy and Henoch-Sch\u00f6nlein purpura. Preliminary results of a prospective uncontrolled trial. Nephron. 1995;69:327\u201334.","journal-title":"Nephron"},{"key":"735_CR42","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1053\/j.ajkd.2011.12.015","volume":"59","author":"JF Augusto","year":"2012","unstructured":"Augusto JF, Sayegh J, Delapierre L, et al. Addition of plasma exchange to glucocorticosteroids for the treatment of severe Henoch-Sch\u00f6nlein purpura in adults: a case series. Am J Kidney Dis. 2012;59:663\u20139.","journal-title":"Am J Kidney Dis"},{"key":"735_CR43","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1007\/s10157-016-1336-y","volume":"21","author":"M Kawabe","year":"2017","unstructured":"\u2022 Kawabe M, Yamamoto I, Komatsuzaki Y, et al. Recurrence and graft loss after renal transplantation in adults with IgA vasculitis. Clin Exp Nephrol. 2017;21:714\u201320. Recurrences occurred in almost a third of the adults with nephritis associated to IgA vasculitis who required renal transplantation. None of them experienced graft loss","journal-title":"Clin Exp Nephrol"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11926-018-0735-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-018-0735-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-018-0735-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,13]],"date-time":"2019-10-13T21:53:20Z","timestamp":1571003600000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11926-018-0735-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,2]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["735"],"URL":"https:\/\/doi.org\/10.1007\/s11926-018-0735-3","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,2]]},"assertion":[{"value":"2 April 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"24"}}